The HER2xHER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions Meeting Abstract
| Authors: | Odintsov, I.; Khodos, I.; Espinosa-Cotton, M.; Lui, A. J.; Mattar, M.; Schram, A. M.; Schackmann, R. C.; Lammerts van Bueren, J.; Geuijen, C. A.; de Stanchina, E.; Ladanyi, M.; Somwar, R. |
| Abstract Title: | The HER2xHER3 bi-specific antibody Zenocutuzumab is effective at blocking growth of tumors driven by NRG1 gene fusions |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263502352 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-956 |
| Notes: | Meeting Abstract: 956 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work